1. Home
  2. FLGC vs GLYC Comparison

FLGC vs GLYC Comparison

Compare FLGC & GLYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGC
  • GLYC
  • Stock Information
  • Founded
  • FLGC 2019
  • GLYC 2003
  • Country
  • FLGC United States
  • GLYC United States
  • Employees
  • FLGC N/A
  • GLYC N/A
  • Industry
  • FLGC Biotechnology: Pharmaceutical Preparations
  • GLYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLGC Health Care
  • GLYC Health Care
  • Exchange
  • FLGC Nasdaq
  • GLYC Nasdaq
  • Market Cap
  • FLGC 17.3M
  • GLYC 17.0M
  • IPO Year
  • FLGC 2021
  • GLYC 2014
  • Fundamental
  • Price
  • FLGC $0.90
  • GLYC $0.26
  • Analyst Decision
  • FLGC Strong Buy
  • GLYC Hold
  • Analyst Count
  • FLGC 4
  • GLYC 2
  • Target Price
  • FLGC $5.67
  • GLYC N/A
  • AVG Volume (30 Days)
  • FLGC 260.6K
  • GLYC 455.3K
  • Earning Date
  • FLGC 11-13-2024
  • GLYC 11-13-2024
  • Dividend Yield
  • FLGC N/A
  • GLYC N/A
  • EPS Growth
  • FLGC N/A
  • GLYC N/A
  • EPS
  • FLGC N/A
  • GLYC N/A
  • Revenue
  • FLGC $64,154,000.00
  • GLYC $10,000.00
  • Revenue This Year
  • FLGC N/A
  • GLYC N/A
  • Revenue Next Year
  • FLGC $8.94
  • GLYC N/A
  • P/E Ratio
  • FLGC N/A
  • GLYC N/A
  • Revenue Growth
  • FLGC N/A
  • GLYC N/A
  • 52 Week Low
  • FLGC $0.75
  • GLYC $0.14
  • 52 Week High
  • FLGC $2.93
  • GLYC $3.52
  • Technical
  • Relative Strength Index (RSI)
  • FLGC 37.58
  • GLYC 44.21
  • Support Level
  • FLGC $0.88
  • GLYC $0.19
  • Resistance Level
  • FLGC $1.00
  • GLYC $0.28
  • Average True Range (ATR)
  • FLGC 0.08
  • GLYC 0.02
  • MACD
  • FLGC 0.01
  • GLYC 0.00
  • Stochastic Oscillator
  • FLGC 16.75
  • GLYC 17.00

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

About GLYC GlycoMimetics Inc.

GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.

Share on Social Networks: